Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Sodium Channel
    (2)
  • AhR
    (1)
  • Nucleoside Antimetabolite/Analog
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

purkinje cells

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | Inhibitors_Agonists
  • Recombinant Protein
    8
    TargetMol | Recombinant_Protein
5-Ethynyluridine
T3697169075-42-9
5-Ethynyluridine is a clickable form of uridine.1It is incorporated into cellular RNA, but not DNA, and has been used to detect transcriptionin vitroandin vivo. 1.Jao, C.Y., and Salic, A.Exploring RNA transcription and turnover in vivo by using click chemistryProc. Natl. Acad. Sci. USA105(41)15779-15784(2008)
  • Inquiry Price
4-6 weeks
Size
QTY
E 0747 FA
E 0747 FA(99599-78-7 Free base)
T24021L In house
E 0747 FA is an antiarrhythmic compound that inhibits the voltage of action potential Vmax in Purkinje fibers of porcine heart.E 0747 FA inhibits Na channels in cardiac cells.
  • Inquiry Price
Size
QTY
Mexiletine hydrochloride
Mexiletine HCl, KOE-1173 (hydrochloride), KO1173
T10465370-01-4
Mexiletine hydrochloride (KOE-1173 hydrochloride) is a voltage-gated sodium channel blocker and a Class IB antiarrhythmic drug. Mexiletine hydrochloride exerts antiarrhythmic effects by inhibiting sodium current in myocardial cells, thereby reducing the rise rate of cardiac action potential (phase 0) and reducing the automaticity of Purkinje fibers.
  • Inquiry Price
Size
QTY
EGIS-8332
T69806220725-87-1
EGIS-8332 is a potent and selective non-competitive AMPA receptor antagonist. EGIS-8332 inhibits AMPA kainate ion channels and cell death. EGIS-8332 inhibited AMPA currents in rat cerebellar Purkinje cells and inhibited the AMPA- and quisqualate-induced excitotoxicity in primary cultures of telencephalon neurons (IC(50)=5.1-9.0 microM), in vitro. EGIS-8332 seems suitable for further development for the treatment of epilepsy, ischaemia and stroke based on its efficacy in a variety of experimental disease models, and on its low side effect potential.
  • Inquiry Price
6-8 weeks
Size
QTY